Skip to content

CT Based Definition of a Tissue Window for Acute Stroke Thrombolysis

Observational Study of Multimodal CT in Acute Ischemic Stroke to Define a Tissue Window for Thrombolysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00463281
Acronym
CT-DEFINE
Enrollment
100
Registered
2007-04-20
Start date
2007-01-31
Completion date
2009-01-31
Last updated
2009-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, ischemic, computed tomography, thrombolysis

Brief summary

Aim of this study is to define a CT-based tissue window for stroke thrombolysis. Our primary hypothesis is that 1. patients with a tissue window (favourable non-contrast CT (NCCT) scan and an intracranial occlusion on CT angiography (CTA) or perfusion-CT-mismatch (area of reduced cerebral blood flow (CBF) \> area of reduced cerebral blood volume (CBV)) represent a significant proportion (\> 20%)of acute stroke patients and therefore are an important target group for future interventional studies 2. patients with a tissue window suffer an unfavourable outcome (\> 50 % mRS =\>4 at 3 months)if the occluded artery was not recanalized.

Interventions

None listed

Sponsors

Technische Universität Dresden
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ischemic anterior circulation stroke * last seen normal \< 12 hours * stroke severity =\> 3 on the National Institute of Health Stroke Scale * multimodal CT stroke protocol performed * informed consent obtained

Exclusion criteria

* premorbid modified Rankin Scale score \> 3 * contraindications to contrast media application * pregnancy or breast feeding * subacute stroke \> 50 % of MCA territory * CT evidence of non-vascular cause of stroke symptoms

Design outcomes

Primary

MeasureTime frame
modified Rankin Scale scores 0-290 days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026